Alkaloid AD Skopje (XMAE:ALK) Net Income: MKD1,831 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAE:ALK Alkaloid AD Skopje XMAE:ALK
100 GF Score
Price MKD22,600.00
GF Value MKD27,037.69
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Alkaloid AD Skopje Net Income?

Alkaloid AD Skopje XMAE:ALK -0.88% 100 Net Income is MKD1,831 Mil as of Jun. 2026. GuruFocus rates XMAE:ALK with a GF Score™ of 100/100 and a GF Value™ of MKD27,037.69 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Alkaloid AD Skopje's Net Income for the three months ended in Jun. 2026 was MKD375 Mil. Its Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was MKD1,831 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Alkaloid AD Skopje's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was MKD266.08.


Alkaloid AD Skopje  (XMAE:ALK) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Alkaloid AD Skopje's Earnings per Share (Diluted) (EPS) for the quarter that ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Alkaloid AD Skopje Net Income Related Terms


Alkaloid AD Skopje Net Income Historical Data

* Premium members only.

The historical data trend for Alkaloid AD Skopje's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkaloid AD Skopje Net Income Chart

Alkaloid AD Skopje Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,304.99 1,463.43 1,576.91 1,684.05 1,795.79

Alkaloid AD Skopje Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 364.04 631.72 308.33 515.61 374.90
XMAE:ALK
100GF Score
Alkaloid AD Skopje XMAE:ALK
Net Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkaloid AD Skopje Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Alkaloid AD Skopje's Net Income for the fiscal year that ended in Dec. 2025 is calculated as

Net Income(A: Dec. 2025 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=2088.633+-292.867+0+0.023000000000138
=1,796

Alkaloid AD Skopje's Net Income for the quarter that ended in Jun. 2026 is calculated as

Net Income(Q: Jun. 2026 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=429.768+-54.868+0+0
=375

Net Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD1,831 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Income →
What does a Net Income of MKD1,831 Mil mean?
Alkaloid AD Skopje (XMAE:ALK) has a Net Income of MKD1,831 Mil as of Jun. 2026. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Alkaloid AD Skopje and its competitors.
Is Alkaloid AD Skopje's Net Income too high?
Alkaloid AD Skopje's current Net Income is MKD1,831 Mil. Overall, Alkaloid AD Skopje has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkaloid AD Skopje's Net Income compare to ZTS and UTHR?
Alkaloid AD Skopje's Net Income of MKD1,831 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income for a Drug Manufacturers company?
A good Net Income depends on the Drug Manufacturers industry context. However, Net Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income mean?
A high Net Income can signal that a stock is expensive relative to its fundamentals. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Alkaloid AD Skopje and its competitors. Alkaloid AD Skopje's current Net Income is MKD1,831 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkaloid AD Skopje stock overvalued right now?
Based on GuruFocus' analysis, Alkaloid AD Skopje (XMAE:ALK) is currently considered Modestly Undervalued. The stock's GF Value™ is MKD27,037.69, compared to a current price of MKD22,600.00 — trading 16.4% below its estimated fair value. The current Net Income is MKD1,831 Mil. Alkaloid AD Skopje's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income calculated?
Net Income is calculated from a company's financial statements. For Alkaloid AD Skopje (XMAE:ALK), the current Net Income is MKD1,831 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?

Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued. The current stock price of MKD22,600.00 is trading 16.4% below its estimated GF Value™ of MKD27,037.69. GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.

Key valuation signals for XMAE:ALK:

  • Net Income: MKD1,831 Mil
  • GF Value™: MKD27,037.69 vs. price of MKD22,600.00 (16.4% below fair value)
  • GF Score™: 100/100 with 1 warning sign

No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alkaloid AD Skopje Business Description

Address Boulevard Aleksandar, Makedonski 12, Skopje, MKD, 1000
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.
100GF Score

Get the complete analysis for XMAE:ALK

Net Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MKD22,600.00
Price
MKD27,037.69
GF Value